Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06536088

The Relationship Between Gait and Severity of Femoroacetabular Impingement

In this study, the spatiotemporal gait parameters of symptomatic femoroacetabular impingement (FAI) patients scheduled for hip arthroscopy are evaluated. Radiological measurements, including the Alpha angle (AA), Lateral Center-Edge Angle (LCEA), and Kellgren-Lawrence (KL) osteoarthritis classification, are recorded from patient files. The relationship between these radiological measurements and walking parameters is assessed. Additionally, the spatiotemporal gait parameters of FAI patients are compared with those of a healthy control group.

Walking assessments provide valuable insights into how Femoroacetabular Impingement (FAI) affects movement and aid in evaluating treatment outcomes. Research indicates that individuals with FAI experience reduced hip motion and slower walking speeds. By analyzing spatiotemporal gait parameters-such as gait velocity, cadence, step length, and vertical center of mass-the impact of FAI on walking can be better understood, leading to the development of targeted treatment strategies. The goal is to explore the correlation between these gait parameters and imaging-based FAI characteristics in affected individuals.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Observational

Primary location

About this study

Patients and control groups are compared using the paired samples t-test for parametric data and the Wilcoxon signed ranks test for nonparametric data. The relationship between gait parameters and imaging-based FAI characteristics is examined by calculating the Pearson correlation coefficient (r) for parametric data and the Spearman rank correlation coefficient (rho) for non-parametric data.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with femoroacetabular impingement scheduled for hip arthroscopy

Exclusion criteria

  • Severe hip osteoarthritis
  • Hip dysplasia
  • Previous ipsilateral and/or contralateral hip surgery,
  • Any orthopedic or neurologic pathology that may affect gait patterns

Treatment and study plan

Walking assesment

Other

Spatiotemporal walking assessments are performed using the Gait Analyzer app (version 0.9.95.0) on a smartphone. Participants who can walk independently without assistance walk a 25-meter path at their normal speed, with the smartphone securely attached to their body above the third lumbar vertebra using a belt. The app records gait velocity, cadence, step time, step length, and vertical center of mass for all participants.

Primary outcomes

  1. Gait velocity

    Time frame: Baseline

    Gait velocity, also known as walking speed, is a crucial parameter in spatiotemporal gait analysis. It refers to the rate at which an individual walks over a given distance and is typically measured in meters per second (m/s).

  2. Cadence

    Time frame: Baseline

    Cadence refers to the number of steps a person takes per minute while walking.

  3. Step length

    Time frame: Baseline

    Step length refers to the distance covered between two consecutive footfalls of opposite feet.

  4. Vertical center of mass

    Time frame: Baseline

    The vertical center of mass refers to the vertical position of the body's center of mass during walking. It is the point where the body's mass is considered to be concentrated and it fluctuates as the person moves.

Study contacts

Contact information is provided by the study sponsor or research team.

İnci H Ayas, Msc

CONTACT

[email protected]

05071740342

Sponsors and collaborators

Lead sponsor

Gazi University

Other

Registry information

Official study title

The Relationship Between Spatiotemporal Gait Parameters and Imaging-based Characteristics of Femoroacetabular Impingement (FAI) in Symptomatic Individuals

Important dates

Study start
2022
Primary completion
2024
Study completion
2024
First posted
Aug 2, 2024
Registry last updated
Aug 2, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.